SUPER HERBS 350 mg, 30 capsules per bottle.
Published June 1, 2016 · Recall initiated: November 23, 2015
Summary
FDA records drug Class I recall D-0909-2016, published June 1, 2016 and initiated November 23, 2015. Recalling firm: Super Herbs; Status: Terminated; Reported quantity: 9 bottles; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Super Herbs
- Distributor
- 9 consignees - only 9 bottles distributed
- Lot
- All lots
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALicorice Coughing Liquid (guaifenesin), 5%, 3.38 fl. oz. (100 ml), OTC, Manufactured by: Ma Ying LongJune 1, 2016
- FDAOrganic Auricularia auricular (Dried Mushroom Powder (Jelly Ear Mushroom). 60 kg 4 mil polyethylene bagsJune 1, 2016
- FDAZhen Gong Fu, packaged in BIG BOX (16 small boxes / 2 capsules per box / 32 capsules), Distributed by: RJune 1, 2016
- FDAAA USA Trading Inc. Ginger Slice Net Wt: 8 oz., AA USA Trading Inc. 47 Reid St. South River, NJ 08882June 1, 2016
- FDASamurai-X, packaged in BIG BOX (24 individually wrapped capsules), Distributed by: R Thomas Marketing, LLC,June 1, 2016
- FDAUndisputed , all lot codes, Flavors: Blue Raspberry, 330 grams packed in 20oz HDPE White Plastic Container,June 1, 2016
Questions about this recall
Was SUPER HERBS 350 mg, 30 capsules per bottle. recalled?
Yes. FDA published recall D-0909-2016 on June 1, 2016. Reported hazard: Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit